Clinical Trial Update: A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cobicistat in combination with gemcitabine and nab-paclitaxel in advanced or metastatic pancreatic ductal adenocarcinoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Cobicistat (cobicistat)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: German Cancer Research Center | Conditions: CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: TERMINATED